Phenyl(thio)phosphon(amid)ate Benzenesulfonamides as Potent and Selective Inhibitors of Human Carbonic Anhydrases II and VII Counteract Allodynia in a Mouse Model of Oxaliplatin-Induced Neuropathy

被引:23
|
作者
Nocentini, Alessio [2 ]
Alterio, Vincenzo [1 ]
Bua, Silvia [2 ]
Micheli, Laura [3 ]
Esposito, Davide [1 ]
Buonanno, Martina [1 ]
Bartolucci, Gianluca [2 ]
Osman, Sameh M. [4 ]
ALOthman, Zeid A. [4 ]
Cirilli, Roberto [5 ]
Pierini, Marco [6 ]
Monti, Simona Maria [1 ]
Mannelli, Lorenzo Di Cesare [3 ]
Gratteri, Paola [2 ]
Ghelardini, Carla [3 ]
De Simone, Giuseppina [1 ]
Supuran, Claudiu T. [2 ]
机构
[1] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy
[2] Univ Florence, Dept NEUROFARBA, Pharmaceut & Nutraceut Sect, I-50019 Sesto Fiorentino, Italy
[3] Univ Florence, Dept NEUROFARBA, Pharmacol & Toxicol Sect, I-50139 Florence, Italy
[4] King Saud Univ, Coll Sci, Chem Dept, Riyadh 11451, Saudi Arabia
[5] Ist Super Sanita, Ctr Nazl Controllo & Valutaz Farm, I-00161 Rome, Italy
[6] Sapienza Univ Rome, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy
关键词
NOCICEPTIN/ORPHANIN FQ RECEPTOR; CRYSTAL-STRUCTURE; CHRONIC PAIN; STRATEGY; ERRORS; BRAIN;
D O I
10.1021/acs.jmedchem.9b02135
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Human carbonic anhydrase (CA; EC 4.2.1.1) isoforms II and VII are implicated in neuronal excitation, seizures, and neuropathic pain (NP). Their selective inhibition over off-target CAs is expected to produce an anti-NP action devoid of side effects due to promiscuous CA modulation. Here, a drug design strategy based on the observation of (dis)similarities between the target CA active sites was planned with benzenesulfonamide derivatives and, for the first time, a phosphorus-based linker. Potent and selective CA II/VII inhibitors were identified among the synthesized phenyl(thio)phosphon(amid)ates 3-22. X-ray crystallography depicted the binding mode of phosphonic acid 3 to both CAs II and VII. The most promising derivatives, after evaluation of their stability in acidic media, were tested in a mouse model of oxaliplatin-induced neuropathy. The most potent compound racemic mixture was subjected to HPLC enantioseparation, and the identification of the eutomer, the (S)-enantiomer, allowed to halve the dose totally relieving allodynia in mice.
引用
收藏
页码:5185 / 5200
页数:16
相关论文
empty
未找到相关数据